MedPath

UNIVERSITY OF SOUTHERN CALIFORNIA

UNIVERSITY OF SOUTHERN CALIFORNIA logo
🇺🇸United States
Ownership
Private
Established
1880-01-01
Employees
10K
Market Cap
-
Website
http://startusc.com

Allograft Adipose Injectable for Vocal Fold Paralysis

Phase 3
Recruiting
Conditions
Vocal Fold Palsy
Interventions
Biological: Renuva Allograft Adipose Matrix
First Posted Date
2021-01-08
Last Posted Date
2023-02-06
Lead Sponsor
University of Southern California
Target Recruit Count
50
Registration Number
NCT04700566
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

Virtual Reality Study - COVID-19 Protocol

Not Applicable
Completed
Conditions
Healthy Aging
Interventions
Behavioral: Physical and Cognitive Activity
First Posted Date
2020-12-22
Last Posted Date
2021-04-29
Lead Sponsor
University of Southern California
Target Recruit Count
14
Registration Number
NCT04678778
Locations
🇺🇸

Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California, Los Angeles, California, United States

Glycemic Targets for Pregnant Women With GDM and T2DM

Not Applicable
Recruiting
Conditions
Diabetes Mellitus, Type 2
Diabetes, Gestational
Diabetes Mellitus in Pregnancy
Interventions
Other: Glycemic Targets
First Posted Date
2020-12-17
Last Posted Date
2023-05-11
Lead Sponsor
University of Southern California
Target Recruit Count
120
Registration Number
NCT04672031
Locations
🇺🇸

Los Angeles County + University of Southern California Medical Center (LAC+USC), Los Angeles, California, United States

The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.

Completed
Conditions
Obesity
First Posted Date
2020-12-17
Last Posted Date
2024-12-06
Lead Sponsor
University of Southern California
Target Recruit Count
93
Registration Number
NCT04674033
Locations
🇺🇸

Children's Hospital Los Angeles, Los Angeles, California, United States

Comprehensive and Continuous Status Measurement of Pre- and Post-Deployment Warfighters with Mobile Application

Not Applicable
Conditions
Military Operations
Military Activity
Interventions
Device: Study App and Apple Watch
First Posted Date
2020-12-17
Last Posted Date
2024-12-11
Lead Sponsor
University of Southern California
Target Recruit Count
500
Registration Number
NCT04672811
Locations
🇺🇸

Ft. Bragg, Fayetteville, North Carolina, United States

🇺🇸

Camp Pendleton, Oceanside, California, United States

Factors Affecting Split Thickness Skin Graft Success Rates in Patients Who Underwent a Radial Forearm or Fibula Free Flap

Not Applicable
Recruiting
Conditions
Skin Graft Complications
Interventions
Other: Cast and bolster placement duration
Other: Standard of care
First Posted Date
2020-12-01
Last Posted Date
2024-05-21
Lead Sponsor
University of Southern California
Target Recruit Count
220
Registration Number
NCT04648267
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients

Not Applicable
Completed
Conditions
Atopic Dermatitis
Psoriasis
Acne
Interventions
Other: Tailored Patient-Provider Communication
Other: Non-Tailored Patient-Provider Communication
First Posted Date
2020-11-18
Last Posted Date
2022-12-15
Lead Sponsor
University of Southern California
Target Recruit Count
134
Registration Number
NCT04633616
Locations
🇺🇸

USC, Los Angeles, California, United States

¡Vivir Mi Vida! Pilot Study

Not Applicable
Completed
Conditions
Healthy Lifestyle
First Posted Date
2020-11-10
Last Posted Date
2020-11-12
Lead Sponsor
University of Southern California
Registration Number
NCT04623489
Locations
🇺🇸

University of Southern California, Los Angeles, California, United States

In Situ Immunomodulation with CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients W/ Unresectable and Metastatic Solid Tumors

Phase 1
Recruiting
Conditions
Unresectable Melanoma
Cutaneous Squamous Cell Carcinoma
Merkel Cell Carcinoma
Soft Tissue Sarcoma
Bone Sarcoma
Sarcoma,Soft Tissue
Anatomic Stage IV Breast Cancer AJCC V8
Metastatic Breast Carcinoma
Prognostic Stage IV Breast Cancer AJCC V8
Unresectable Breast Carcinoma
Interventions
Biological: Anti-CD40 Agonist Monoclonal Antibody CDX-1140
Radiation: Radiation Therapy
Biological: Recombinant Flt3 Ligand
First Posted Date
2020-11-04
Last Posted Date
2024-12-16
Lead Sponsor
University of Southern California
Target Recruit Count
18
Registration Number
NCT04616248
Locations
🇺🇸

Los Angeles General Medical Center, Los Angeles, California, United States

🇺🇸

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Contrast Enhanced Ultrasound Endoleak Identification and Classification

Not Applicable
Withdrawn
Conditions
Abdominal Aortic Aneurysm
Interventions
Diagnostic Test: Contrast enhanced ultrasound
First Posted Date
2020-11-04
Last Posted Date
2022-11-14
Lead Sponsor
University of Southern California
Registration Number
NCT04615559
Locations
🇺🇸

USC Department of Radiology, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath